K121902

Substantially Equivalent

NATRATONE

Applicant: Orelle Corporation, Ltd.
Product code: HIR
Advisory panel: Obstetrics/Gynecology
Date received: 2012-06-29
Decision date: 2013-06-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seattle, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.